Your browser doesn't support javascript.
loading
Comparison of HER2-targeted affibody conjugates loaded with auristatin- and maytansine-derived drugs.
Yin, Wen; Xu, Tianqi; Ding, Haozhong; Zhang, Jie; Bodenko, Vitalina; Tretyakova, Maria S; Belousov, Mikhail V; Liu, Yongsheng; Oroujeni, Maryam; Orlova, Anna; Tolmachev, Vladimir; Gräslund, Torbjörn; Vorobyeva, Anzhelika.
Afiliação
  • Yin W; Department of Protein Science, KTH Royal Institute of Technology, Roslagstullsbacken 21, 114 17 Stockholm, Sweden. Electronic address: wenyin@kth.se.
  • Xu T; Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden. Electronic address: tianqi.xu@igp.uu.se.
  • Ding H; Department of Protein Science, KTH Royal Institute of Technology, Roslagstullsbacken 21, 114 17 Stockholm, Sweden. Electronic address: haozhong@kth.se.
  • Zhang J; Department of Protein Science, KTH Royal Institute of Technology, Roslagstullsbacken 21, 114 17 Stockholm, Sweden. Electronic address: jiezha@kth.se.
  • Bodenko V; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia.
  • Tretyakova MS; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia.
  • Belousov MV; Siberian State Medical University, Ministry of Health of the Russian Federation, 634050 Tomsk, Russia; National Research Tomsk Polytechnic University, 634050 Tomsk, Russia.
  • Liu Y; Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden. Electronic address: yongsheng.liu@igp.uu.se.
  • Oroujeni M; Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden. Electronic address: maryam.oroujeni@igp.uu.se.
  • Orlova A; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia; Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden; Science for Life Laboratory, Uppsala University, 751 23 Uppsala, Swe
  • Tolmachev V; Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia. Electronic address: vladimir.tolmachev@igp.uu.se.
  • Gräslund T; Department of Protein Science, KTH Royal Institute of Technology, Roslagstullsbacken 21, 114 17 Stockholm, Sweden. Electronic address: torbjorn@kth.se.
  • Vorobyeva A; Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden. Electronic address: anzhelika.vorobyeva@igp.uu.se.
J Control Release ; 355: 515-527, 2023 03.
Article em En | MEDLINE | ID: mdl-36773960
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Maitansina / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Maitansina / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article